Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- CIPLA.NSE
- Price
- 1415.60
- Stock movement down
- -16.95 (-1.18%)
- Company name
- Cipla Limited
- Exchange
- (NSE ,
- Currency
- INR )
- Sector
- Healthcare >Drug Manufacturers - General
- Market cap
- 1143.26B
- Ent value
- 1197.28B
- Price/Sales
- 4.33
- Price/Book
- 4.02
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 25.55
- Forward P/E
- 25.62
- PEG
- -
- EPS growth
- 21.92%
- 1 year return
- -3.01%
- 3 year return
- 11.22%
- 5 year return
- 29.10%
- 10 year return
- 7.89%
Last updated: 2025-04-10
DIVIDENDS
CIPLA.NSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 25.55 |
| Price to OCF | 244.88 |
| Price to FCF | 244.88 |
| Price to EBITDA | 59.17 |
| EV to EBITDA | 61.97 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 4.33 |
| Price to Book | 4.02 |
| EV to Sales | 4.53 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 807.61M |
| EPS (TTM) | 55.38 |
| FCF per share (TTM) | 5.78 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 264.14B |
| Gross profit (TTM) | 133.75B |
| Operating income (TTM) | 58.09B |
| Net income (TTM) | 44.75B |
| EPS (TTM) | 55.38 |
| EPS (1y forward) | 55.25 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 50.64% |
| Operating margin (TTM) | 21.99% |
| Profit margin (TTM) | 16.94% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 7.98B |
| Net receivables | 55.88B |
| Total current assets | 209.45B |
| Goodwill | 32.51B |
| Intangible assets | 18.60B |
| Property, plant and equipment | 62.17B |
| Total assets | 346.55B |
| Accounts payable | 26.75B |
| Short/Current long term debt | 4.61B |
| Total current liabilities | 54.55B |
| Total liabilities | 61.99B |
| Shareholder's equity | 284.56B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 4.67B |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 4.67B |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 15.73% |
| Return on Assets | 12.91% |
| Return on Invested Capital | 15.59% |
| Cash Return on Invested Capital | 1.63% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1416.50 |
| Daily high | 1423.00 |
| Daily low | 1396.05 |
| Daily Volume | 1.70M |
| All-time high | 1683.00 |
| 1y analyst estimate | 1629.72 |
| Beta | 0.34 |
| EPS (TTM) | 55.38 |
| Dividend per share | - |
| Ex-div date | 1 Aug 2024 |
| Next earnings date | 8 May 2025 |
Downside potential
Loading...
Downside potential data
| CIPLA.NSE | S&P500 | |
| Current price drop from All-time high | -15.89% | -10.49% |
| Highest price drop | -86.67% | -56.47% |
| Date of highest drop | 29 Apr 2003 | 9 Mar 2009 |
| Avg drop from high | -37.50% | -11.07% |
| Avg time to new high | 50 days | 12 days |
| Max time to new high | 2566 days | 1805 days |
COMPANY DETAILS
Marketcap
1143.26B
Marketcap category
Large-cap
Description
Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Employees
27764
Website
Investor relations
-
SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found